CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $158,000 | -15.5% | 6,163 | -21.8% | 0.00% | – |
Q2 2022 | $187,000 | -12.6% | 7,877 | -17.1% | 0.00% | – |
Q1 2022 | $214,000 | -71.3% | 9,506 | -74.8% | 0.00% | -100.0% |
Q4 2021 | $746,000 | -48.8% | 37,696 | -49.1% | 0.00% | -66.7% |
Q3 2021 | $1,456,000 | -73.3% | 74,000 | -70.2% | 0.00% | -66.7% |
Q2 2021 | $5,458,000 | -41.8% | 248,100 | -37.0% | 0.01% | -43.8% |
Q1 2021 | $9,370,000 | -50.3% | 393,900 | -45.3% | 0.02% | -52.9% |
Q4 2020 | $18,845,000 | -31.7% | 720,400 | -54.5% | 0.03% | -39.3% |
Q3 2020 | $27,585,000 | -0.0% | 1,584,900 | -3.4% | 0.06% | -1.8% |
Q2 2020 | $27,586,000 | +23.2% | 1,640,081 | -12.9% | 0.06% | +5.6% |
Q1 2020 | $22,396,000 | +7.7% | 1,883,624 | +9.6% | 0.05% | +68.8% |
Q4 2019 | $20,792,000 | +35.0% | 1,718,424 | +57.7% | 0.03% | +28.0% |
Q3 2019 | $15,398,000 | +148.8% | 1,089,386 | +96.3% | 0.02% | +150.0% |
Q2 2019 | $6,189,000 | +367.1% | 555,100 | +391.7% | 0.01% | +400.0% |
Q1 2019 | $1,325,000 | -12.1% | 112,900 | 0.0% | 0.00% | -33.3% |
Q4 2018 | $1,508,000 | – | 112,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |